Abstract:Within the last decade, the development of effective monovalent vaccines has provided a major advance in the prevention of both hepatitis A and B. We have previously reviewed these vaccines.1,2 Now, combined (bivalent) hepatitis A and B vaccines have been licensed (▼Twinrix Adult and ▼Twinrix Paediatric-SmithKline Beecham). Here we consider the potential uses for such combined vaccines.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.